Dexmedetomidine as an Adjuvant During Dural Puncture Epidural

Starting soon · Not applicable

Conditions studied: Total Dose of Bupivacaine Administered During Labor

In brief

The study aimed to determine the effects of using varied doses of DEX on the concentration of bupivacaine injected for epidural labor analgesia, and to assess the benefits of the dural puncture epidural.

Key facts

Study ID

NCT07506044

Run by

Menoufia University

People needed

140

Starts

2026-05-30

Expected to finish

2026-10-30

Last updated by the study team

2026-06-02

Who can join

Age: 18 and older, up to 40. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women who attend the Emergency Department in labor, with cervical dilation of 3-5 cm,
• normally presented singleton fetus, intact fetal membranes, and who are free of exclusion criteria

You may not qualify if…

• Abnormal fetal presentation or lie, 'premature rupture of membranes, maternal fever, fetal distress, pregnancy-induced diseases
• abnormal placental position,
• ASA grade>II
• marked obesity,
• allergy or contraindications to the used drugs,
• spinal deformity or disorders 'cutaneous diseases or infection at the injection site

Where it is running

• Faculty of Medicine Menoufia University — Shebeen El Kom, Egypt

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.